Teneligliptin*
-
API Product :
Teneligliptin*
-
CEP :
-
-
WCC :
-
-
Therapeutic Use :
Anti-Diabetic,Inhibitor of Dipeptidyl Peptidase 4
-
Originator :
Mitsubishi Tanabe Pharma
-
CAS No. :
760937-92-6
-
Trade Name. :
Tenelia
-
Molecular Weight :
426.58 g/mol
-
Molecular Formula :
C22H30N6OS
Application
Teneligliptin has been commercially sold in Japan and has been used for the treatment of type 2 diabetes mellitus when patients do not show sufficient improvement after diet control and exercise or a combination of diet control, exercise, and sulfonylurea- or thiazolidine-class drugs.
General Description
Teneligliptin (INN; trade name Tenelia) is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or "gliptins.